Founded with a mission to revolutionize temperature-controlled transportation, Artyc specializes in cold shipping solutions for biotech, pharmaceutical, and medical goods. The company aims to provide reliable and high-quality logistics services that ensure the integrity of sensitive products. Artyc's offerings include specialized shipping containers like Medstow Micro for precision blood shipping and the upcoming Medstow 5L and Terrastow 25L for biologics and food logistics. Their market focus is on industries requiring stringent temperature control to maintain product efficacy.
Artyc has recently closed a successful Series A funding round, marking a significant milestone in its growth trajectory. The company is backed by notable investors who share its vision of enhancing cold chain logistics. Key achievements include the launch of innovative shipping solutions that have set new standards in the industry. Artyc's impact is evident in its ability to deliver critical medical and biotech products reliably, thereby supporting advancements in healthcare and research.
